Sub-acute toxicity study of a new aminoglycoside etimicin sulphate in swiss albino mice

Journal of Toxicological Sciences

Volumn 35, Issue 4, 2010, Pages 479-484

  Payasi, Anurag ^a   Chaudhary, Manu ^a   Gupta, Ankush ^a   Dwivedi, Vivek Kumar ^a  

^a Hill Top Industrial Estate   (India)

Author keywords

Aminoglycosids; Bacterial infections; Etimicin; Sub acute

Indexed keywords

ETIMICIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; TOXICITY TESTING;

BACTERIA (MICROORGANISMS); MUS;

EID: 77956817178     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.35.479     Document Type: Article

References (26)

1. Ali, M.Z. and Goetz, M.B. (1997): A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clin. Infect. Dis., 24, 796-809.
2. Bailey, T.C., Little, J.R., Littenberg, B., Reichley, R.M. and Dunagan, W.C. (1997): A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides. Clin. Infect. Dis., 24, 786-795.
3. Caiyun, Z., Jiatai, L.I., Jie, H., Min, G.U.O., ye, Z. and Yifang, C. (2000): A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic versus netilmicin in the treatment of bacterial infection. Chin. Med. J., 113, 1026-1030.
4. Choudhury, D. and Ahmed, Z. (1997): Drug-induced nephrotoxicity. The Med. Clin. North Ame., 81, 705-717.
5. Edson, R.S. and Terrell, C.L. (1991): The aminoglycosides. Mayo Clin. Proc., 66, 1158-1164.
6. Ferriols-Lisart, R. and Alos-Alminana, M. (1996): Effectiveness and safety of once-daily aminoglycosides: a meta-analysis. Amer. J. Health Sys. Phar., 53, 1141-1150.
7. Freeman, C.D. and Strayer, A.H. (1996): Mega-analysis of meta-analysis: an examination of meta-analysis with an emphasis on once-daily aminoglycoside comparative trials. Pharmacotherapy, 16, 1093-1102.
8. Gilbert, D.N. (1995): Aminoglycosides. In: Principles and practice of infectious diseases (Mandell, G.L., Bennett, J.E. and Dolin, R., eds.), pp.279-301, Douglas & Bennett's, Churchill, Livingston, New York.
9. Gonzalez, L.S. 3rd and Spencer, J.P. (1998): Aminoglycosides: a practical review. Am. Fam. Physician, 58, 1811-1820.
10. Hatala, R., Dinh, T.T. and Cook, D.J. (1997): Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review. Clin. Infect. Dis., 24, 810-815.
11. Hock, R. and Anderson, R.J. (1995): Prevention of drug-induced nephrotoxicity in the intensive care unit. J. Crit. Care, 10, 33-43.
12. Huy, B.T.P. and Deffrennes, D. (1988): Aminoglycoside ototoxicity: influence of dosage regimen on drug uptake and correlation between membrane binding and some clinical features. Acta. Otolaryngol., 105, 511-515.
13. Karlowsky, J.A., Zelenitsky, S.A. and Zhanel, G.G. (1997): Aminoglycoside adaptive resistance. Pharmacotherapy, 17, 549-555.
14. Lindblad, A., Hultcrantz, R. and Strandvik, B (1994): High doses of aminoglycosides did not produce liver toxicity in patients with cystic fibrosis. J. Hepatol., 20, 201-205.
15. Li, Q.X., Fang, Y.Y. and Sun, J.H. et al. (1995): Ototoxicity of antibiotic 89-07 with gentamicin and amikacin. Chin. J. Antibiot., 20, 442-447.
16. Lortholary, O., Tod, M., Cohen, Y. and Petitjean, O. (1995): Aminoglycosides. Med. Clin. North Am., 79, 761-787.
17. Montie, T. and Patamasucon, P. (1995): Aminoglycosides: the complex problem of antibiotic mechanisms and clinical applications. Eur. J. Clin. Microbiol. Infect. Dis., 14, 85-87.
18. Neu, H.C. (1992): The crisis in antibiotic resistance. Science, 257, 1064-1073.
19. Nisly, S.A., Ray, S.M., Moye, R.A., Soler, E.M. and larouche, M. (2007): Tobramycin-induced hepatotoxicity. Ann. Pharmacother., 41, 2061-2065.
20. Sundin, D.P., Sandoval, R. and Molitoris, B.A. (2001): Gentamicin inhibits renal protein and phospholipid metabolism in rats: implications involving intracellular trafficking. J. Am. Soc. Nephrol., 12, 114-123.
21. Vogelman, B. and Craig, W.A. (1986): Kinetics of antimicrobial activity. J. Pediatr., 108, 835-840.
22. Wang, H.X., Zhang, L.R., Ma, X.C. and Ma,T.X. (2002): Influence of piperacillin on pharmacokinetics of etimicin in healthy volunteers. Acta Pharmacol. Sinica, 23, 376-380.
23. Wang, P.Y., Li, X.Q. and Fang, Y.Y. et al. (1995): Ototoxicity of antibiotic 89-07 and netil micin in guinea. Chin. J. Antibiot., 20, 448-454.
24. Xi, L., Wu, G. and Zhu, Y. (2006): Analysis of etimicin sulfate by liquid chromatography with pulsed amperometric detection. J. Chromatogr. A, 1115, 202-207.
25. Yalin, L., Yan, Z., Hui, T., Xiaoyu, L., Changyi, S. and Jian, Q. (2006): Effect of etimicin plus other antibacterial on renal function in elderly patients with severe pneumonia. ADRJ, 6, 428-430.
26. Zhao, C., Li, J., Hou, J., Guo, M., Zhang, Y. and Chen, Y. (2000): A randomized controlled clinical trial on etimicin, a new aminoglycoside antibiotic, versus netilmicin in the treatment of bacterial infections. Chin. Med. J., 113, 1026-1030.